232 related articles for article (PubMed ID: 31477270)
21. Ribophorin II potentiates P-glycoprotein- and ABCG2-mediated multidrug resistance via activating ERK pathway in gastric cancer.
Zhang H; Jiang H; Zhang H; Liu J; Hu X; Chen L
Int J Biol Macromol; 2019 May; 128():574-582. PubMed ID: 30710584
[TBL] [Abstract][Full Text] [Related]
22. Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo.
Chen M; Huang SL; Zhang XQ; Zhang B; Zhu H; Yang VW; Zou XP
J Cell Biochem; 2012 Jul; 113(7):2474-87. PubMed ID: 22396185
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of miRNA-200c on chemotherapy-resistance and cell proliferation of gastric cancer SGC7901/DDP cells.
Chen Y; Zuo J; Liu Y; Gao H; Liu W
Chin J Cancer; 2010 Dec; 29(12):1006-11. PubMed ID: 21114921
[TBL] [Abstract][Full Text] [Related]
24. [Correlation of sorcin overexpression to multidrug resistance of human gastric cancer cell line SGC7901].
He QC; Zhang GY; Cao WJ
Ai Zheng; 2008 Apr; 27(4):337-42. PubMed ID: 18423116
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA MRUL promotes ABCB1 expression in multidrug-resistant gastric cancer cell sublines.
Wang Y; Zhang D; Wu K; Zhao Q; Nie Y; Fan D
Mol Cell Biol; 2014 Sep; 34(17):3182-93. PubMed ID: 24958102
[TBL] [Abstract][Full Text] [Related]
26. Interferon regulatory factor-1 reverses chemoresistance by downregulating the expression of P-glycoprotein in gastric cancer.
Yuan J; Yin Z; Tan L; Zhu W; Tao K; Wang G; Shi W; Gao J
Cancer Lett; 2019 Aug; 457():28-39. PubMed ID: 31078735
[TBL] [Abstract][Full Text] [Related]
27. BATF2 reverses multidrug resistance of human gastric cancer cells by suppressing Wnt/β-catenin signaling.
Yang W; Wu B; Ma N; Wang Y; Guo J; Zhu J; Zhao S
In Vitro Cell Dev Biol Anim; 2019 Jun; 55(6):445-452. PubMed ID: 31140101
[TBL] [Abstract][Full Text] [Related]
28. Identification of triosephosphate isomerase as an anti-drug resistance agent in human gastric cancer cells using functional proteomic analysis.
Wang X; Lu Y; Yang J; Shi Y; Lan M; Liu Z; Zhai H; Fan D
J Cancer Res Clin Oncol; 2008 Sep; 134(9):995-1003. PubMed ID: 18309519
[TBL] [Abstract][Full Text] [Related]
29. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD
Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
[TBL] [Abstract][Full Text] [Related]
30. [Multidrug resistance mechanisms in cell line HL-60/VCR].
Zhu XH; Li JY; Xia XM; Zhu MQ; Geng MJ; Chen L; Zhang JQ
Ai Zheng; 2002 Dec; 21(12):1310-3. PubMed ID: 12520737
[TBL] [Abstract][Full Text] [Related]
31. ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting
Tan B; Li Y; Zhao Q; Fan L; Wang D
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30126848
[TBL] [Abstract][Full Text] [Related]
32. C-phycocyanin to overcome the multidrug resistance phenotype in human erythroleukemias with or without interaction with ABC transporters.
Fernandes E Silva E; Figueira FS; Cañedo AD; Machado KS; Salgado MTSF; Silva TK; Wagner EF; Mattozo FH; Lima ÉA; Sales-Neto JM; Ferreira VU; Comitre AA; Mascarenhas SR; Kalil SJ; Votto APS
Biomed Pharmacother; 2018 Oct; 106():532-542. PubMed ID: 29990841
[TBL] [Abstract][Full Text] [Related]
33. Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA library.
Zhao L; Pan Y; Gang Y; Wang H; Jin H; Tie J; Xia L; Zhang Y; He L; Yao L; Qiao T; Li T; Liu Z; Fan D
J Biol Chem; 2009 Sep; 284(39):26273-85. PubMed ID: 19638344
[TBL] [Abstract][Full Text] [Related]
34. MGr1-Ag is associated with multidrug-resistant phenotype of gastric cancer cells.
Shi Y; Han Y; Wang X; Zhao Y; Ning X; Xiao B; Fan D
Gastric Cancer; 2002; 5(3):154-9. PubMed ID: 12378342
[TBL] [Abstract][Full Text] [Related]
35. [Reversal of multidrug resistance of gastric cancer cells by down-regulation of CIAPIN1 with CIAPIN1 siRNA].
Li X; Fan R; Zou X; Hong L; Gao L; Jin H; Du R; He L; Xia L; Fan D
Mol Biol (Mosk); 2008; 42(1):102-9. PubMed ID: 18389626
[TBL] [Abstract][Full Text] [Related]
36. Adenovirus-mediated IL-24 expression enhances the chemosensitivity of multidrug-resistantgastric cancer cells to cisplatin.
Mao Z; Bian G; Sheng W; He S; Yang J; Dong X
Oncol Rep; 2013 Nov; 30(5):2288-96. PubMed ID: 23982423
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of sorcin results in multidrug resistance in gastric cancer cells with up-regulation of P-gp.
He Q; Zhang G; Hou D; Leng A; Xu M; Peng J; Liu T
Oncol Rep; 2011 Jan; 25(1):237-43. PubMed ID: 21109982
[TBL] [Abstract][Full Text] [Related]
38. Tamoxifen reduces P-gp-mediated multidrug resistance via inhibiting the PI3K/Akt signaling pathway in ER-negative human gastric cancer cells.
Mao Z; Zhou J; Luan J; Sheng W; Shen X; Dong X
Biomed Pharmacother; 2014 Mar; 68(2):179-83. PubMed ID: 24184201
[TBL] [Abstract][Full Text] [Related]
39. miR‑1 reverses multidrug resistance in gastric cancer cells via downregulation of sorcin through promoting the accumulation of intracellular drugs and apoptosis of cells.
Deng LM; Tan T; Zhang TY; Xiao XF; Gu H
Int J Oncol; 2019 Aug; 55(2):451-461. PubMed ID: 31268161
[TBL] [Abstract][Full Text] [Related]
40. Overexpression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901/ADR.
Du J; Pan Y; Shi Y; Guo C; Jin X; Sun L; Liu N; Qiao T; Fan D
Int J Cancer; 2005 Jan; 113(2):213-20. PubMed ID: 15386405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
